Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...

The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...

Long-term outcomes after CT or invasive coronary angiography to diagnose CAD were similar, with comparable improvement in ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Patients with eosinophilic esophagitis face significant economic burdens, according to a pair of presentations at Digestive ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for ...

Drug and alcohol references in popular music not only correlate with use, but they also provide opportunities for engaging ...

Children and young adults in states with high Medicaid disenrollment rates were more likely to experience disruptions in ...